1800 202 8726
Cytology report interpretation

What Does — 'Non-Diagnostic' Mean in Cytology?

Seeing 'non-diagnostic' on a cytology report does not mean cancer was found. It means the sample did not have enough cells for the pathologist to reach a conclusion. The report is a statement about the sample, not about what is in your body.

Medically reviewed by Dr. Bharati Devi Gorantla, Medical Oncologist, MBBS · MD · DM (Adyar, Chennai) · ECMO · MRCP SCE (UK) · Last reviewed September 2026

  • Not a cancer finding — Non-diagnostic means the sample was inadequate for analysis, not that cancer is present or absent.
  • Happens for technical reasons — Too few cells, blood mixing with the sample, or a cyst yielding mostly fluid are common causes.
  • Recognised in every system — All major cytology reporting systems include a Category 1 for samples that cannot be assessed.
  • A repeat is the standard step — Most guidelines recommend a repeat biopsy, usually with ultrasound guidance to improve the sample.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Get this explained properly

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Report reviewed by a senior oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

Non-diagnostic is Category 1 in most cytology reporting systems. It means the laboratory received a sample with too few cells, or cells too poorly preserved, to make any diagnosis. It is not a finding of cancer. A repeat biopsy — often ultrasound-guided — is the step most guidelines, including those from NCCN and the American Thyroid Association, recommend next.

Why does a sample come back non-diagnostic?

A cytology sample is called non-diagnostic when the pathologist does not have enough cells of the right type to reach a conclusion.

The most common reason is that the needle drew mostly blood or fluid rather than the tissue cells being targeted.

In cystic lesions — lumps that are partly hollow — the sample often contains mostly fluid with very few cells. Technical factors at the time of sampling, such as a deeply placed lesion or the way the sample was prepared in the laboratory, also contribute.

How do different reporting systems describe an inadequate sample?

FeatureThyroid FNA (Bethesda)Breast FNA (RCPath)Salivary Gland FNA (Milan)
Category numberI (1)C11
Category labelNondiagnostic / UnsatisfactoryInadequate / UnsatisfactoryNon-diagnostic
Common causeCyst fluid, insufficient follicular cells, or obscuring bloodToo few epithelial cells or poor cell preservationSparse cellularity or poor fixation
Usual recommendationRepeat FNA, preferably ultrasound-guidedRepeat FNA with imaging guidanceRepeat FNA with clinical correlation
Governing guidanceCollege of American PathologistsUK Royal College of PathologistsInternational Academy of Cytology

Is a non-diagnostic result common?

Yes. Non-diagnostic results are a recognised and expected part of cytology practice, not an unusual event.

All major reporting systems include a formal Category 1 precisely because these results occur regularly. The rate varies by organ, lesion type, and whether imaging guidance was used during sampling.

Cystic lesions have higher non-diagnostic rates than solid ones because they tend to yield more fluid than cells. Ultrasound guidance during the procedure reduces the chance of a non-diagnostic result, which is why many guidelines recommend it as the preferred technique.

Still unclear?

Send your reports across and a specialist will walk you through what they mean — what is known, what is not, and what the options actually are.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

Get a straight answer from a specialist

45 minutes, your reports reviewed, your questions answered in plain language.

Book Free Consultation Call 1800 202 8726

What do the words in your cytology report mean?

Fine needle aspiration (FNA)
A procedure that uses a thin needle to draw cells from a lump or lymph node for examination under the microscope. It is minimally invasive and usually the first test ordered before more complex investigations.
Cytology
The laboratory study of individual cells. A cytologist examines cell shape and size to assess whether they appear normal, suspicious, or malignant. It differs from histopathology, which examines a larger slice of tissue and preserves the way cells are arranged relative to each other.
Cellularity
The number of cells in a sample. Poor cellularity — too few cells of the right type — is the most common reason for a non-diagnostic result. The pathologist needs a minimum amount of the right material to make a reliable assessment.
Core needle biopsy
A procedure that removes a small cylinder of tissue rather than just loose cells. Because it preserves tissue structure, a core biopsy is often used after repeated non-diagnostic FNA results to get a result that can be interpreted.

What do families most often ask about a non-diagnostic result?

Does this mean the doctor missed cancer?

No. Non-diagnostic is a statement about sample quality, not about whether cancer is present. The needle may have missed the target area or drawn mostly blood. This is why a repeat with imaging guidance is the standard recommended step — it directly addresses the sampling limitation rather than repeating the same technique.

Will a repeat biopsy always give a clear answer?

Not always, but imaging guidance significantly improves the yield on a second attempt. If a guided repeat is also non-diagnostic, your team may move to a core needle biopsy, which removes a small cylinder of tissue and is more likely to return a result that can be interpreted. Your team will advise on the sequence.

How soon should the repeat biopsy be done?

Timing guidance varies by organ. For thyroid nodules, the American Thyroid Association advises waiting some weeks before a repeat, because the small amount of bleeding from the first biopsy can affect sample quality. Your team will give you the specific timeline appropriate for your situation and the organ being sampled.

Should we go to a different hospital for the repeat?

There is no general reason to change hospitals after a non-diagnostic result — it is a recognised outcome, not an error. The change that most improves outcomes is moving from a non-guided to a guided biopsy technique. Seek a second opinion if you have broader concerns about your care, but a non-diagnostic result alone does not indicate that something went wrong with your procedure.

Does this category carry a malignancy risk?

The non-diagnostic category itself does not carry a defined malignancy risk in the way that higher Bethesda or Milan categories do. The risk is unknown rather than low, because the sample could not be assessed at all. For solid nodules that remain non-diagnostic on repeat, some guidelines note that surgical assessment may be appropriate. Your team will advise based on your imaging findings and clinical picture.

Did you know?

Ultrasound guidance during fine needle aspiration is associated with meaningfully lower non-diagnostic rates compared with sampling guided by touch alone. Most current cytology guidelines now recommend it as the preferred technique rather than an optional upgrade.

The Bethesda System for Reporting Thyroid Cytopathology, developed under the College of American Pathologists, introduced standardised category labels partly so that decisions about repeating a biopsy would be consistent across different laboratories and reporting pathologists.

Source: Bethesda System for Reporting Thyroid Cytopathology, College of American Pathologists; American Thyroid Association Management Guidelines

Explore 114 more Waiting For and Understanding Your Report topics

HUB — Cytology and Prostate Scoring Systems Explained

HUB — Understanding Your Biopsy Report

HUB — Waiting for Biopsy Results

All Waiting For and Understanding Your Report →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

What does Category 1 mean on a cytology report?

Category 1 is the non-diagnostic or unsatisfactory category in most major cytology reporting systems — it means the sample could not be assessed. It carries no diagnosis, not even a benign one. The correct next step depends on your clinical situation and imaging findings. Your team will advise whether a repeat biopsy or a different type of sample collection is most appropriate.

Is a non-diagnostic FNA result a bad sign?

No — a non-diagnostic result is a technical outcome, not a clinical one. It tells you about the sample, not about what is in your body. Many people with non-diagnostic first samples go on to have a completely interpretable result on repeat. What matters is that a repeat is arranged so you can get a result that actually means something.

What happens if the repeat biopsy is also non-diagnostic?

If a second sample is also inadequate, your team may recommend a core needle biopsy, which takes a small cylinder of tissue rather than just cells. For thyroid nodules that are repeatedly non-diagnostic but look solid on imaging, some guidelines suggest surgical assessment so the nodule can be examined fully. Your team will weigh the imaging findings, your clinical history, and your preferences before advising.

Can cytology miss cancer even when the result is not non-diagnostic?

Yes, and this matters. Even a sample reported as benign carries a small false-negative rate, which varies by organ and reporting system. This is why cytology results are always read alongside imaging and your clinical picture, not in isolation. If imaging or examination suggests something is concerning despite a reassuring cytology, your team may still recommend further investigation.

How is cytology different from a tissue biopsy?

Cytology examines individual cells collected by a thin needle. A core or surgical biopsy examines a piece of tissue and preserves the arrangement of cells — information cytology cannot provide. Cytology is faster and less invasive and is usually the first step. Core biopsy is used when cytology is repeatedly non-diagnostic or when a result needs confirmation before a major treatment decision is made.

Will CION arrange the repeat biopsy?

Yes. FNA and core needle biopsies are part of the diagnostic workup at CION centres, and ultrasound guidance can be arranged to improve sample quality. PET-CT and other response-assessment scans are coordinated with partner imaging centres. If your non-diagnostic result came from a biopsy done elsewhere, your team at CION will advise on the appropriate repeat sampling from your next visit.

Full index

Browse all 701 biopsy topics

Every page in this section, grouped by the part of the journey it belongs to. Pick a group to see what is in it.

What Is a Biopsy?

What Is a Biopsy? Everything You Need to Know →

Types of Biopsy Compared

Which Biopsy Will You Have? Techniques Compared →

Preparing for a Biopsy

What to Expect on the Day of Your Biopsy →

Recovery and Aftercare

After a Biopsy: Recovery, Aftercare and Warning Signs →

Biopsy by Body Part

Biopsy by Body Part: What to Expect at Each Site →

Understanding Your Report

How to Read a Biopsy Report: Terms Explained →

IHC and Molecular Markers

IHC and Molecular Markers on a Biopsy: What They Mean →

Grading and Scoring Systems

Cytology & Prostate Scoring Systems Explained →

How Accurate Is a Biopsy?

How Accurate Is a Biopsy? Errors and Second Opinions →

If Your Result Is Benign

Your Biopsy Is Benign: What It Means and What Comes Next →

Call now Book free consultation